{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T11:24:02Z","timestamp":1784978642357,"version":"3.55.0"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,4,15]],"date-time":"2018-04-15T00:00:00Z","timestamp":1523750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007705","name":"Astellas Pharma Global Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Expectations"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Neuropathic pain (NP) is a complex, chronic pain state initiated by a primary lesion or dysfunction of the nervous system and presents as a variety of symptoms across multiple disease states.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To develop a patient\u2010centred conceptual model of symptoms and impacts in subjects with diabetic peripheral neuropathy (DPN) or post\u2010herpetic neuralgia (PHN) that can inform the measurement strategy in clinical trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Thirty subjects with DPN or PHN participated in in\u2010person interviews which were performed until saturation was achieved. Transcripts were analysed in ATLAS.ti.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Interviews were completed with DPN subjects (United States, n\u00a0=\u00a010; Japan, n\u00a0=\u00a010) and PHN subjects (United States, n\u00a0=\u00a05; Japan, n\u00a0=\u00a05). Numbness and tingling were frequently reported symptoms in the DPN population while itchiness and hypersensitivity were predominant in PHN. Both populations experienced burning and ache\/soreness with similar frequency. DPN subjects experienced pain primarily in their lower extremity (eg feet, ankles), while PHN subjects experienced pain primarily in the chest and back. Impacts reported by DPN subjects included difficulty walking, sleep disturbance and climbing stairs. Impacts in PHN subjects included sleep disturbance, avoidance of physical contact, being angry\/frustrated and being sad\/depressed. Overall, concepts in Japan were not qualitatively different from the United States. Conceptual models of NP were generated based on the concepts elicited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This research highlights core concepts to measure from the patient's perspective. Moreover, it enables the assessment of existing measures, the possible modification of these measures, or if a new NP measure with improved sensitivity and responsiveness is merited.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hex.12673","type":"journal-article","created":{"date-parts":[[2018,4,15]],"date-time":"2018-04-15T19:53:15Z","timestamp":1523821995000},"page":"774-786","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Neuropathic pain: A patient\u2010centred approach to measuring outcomes"],"prefix":"10.1111","volume":"21","author":[{"given":"Steve","family":"Hwang","sequence":"first","affiliation":[{"name":"Endpoint Outcomes  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floortje","family":"van Nooten","sequence":"additional","affiliation":[{"name":"Astellas Pharma B.V.  Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Wells","sequence":"additional","affiliation":[{"name":"Endpoint Outcomes  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisling","family":"Ryan","sequence":"additional","affiliation":[{"name":"Endpoint Outcomes  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Crawford","sequence":"additional","affiliation":[{"name":"IMS Japan K.K.  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Evans","sequence":"additional","affiliation":[{"name":"Endpoint Outcomes  Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3600-5677","authenticated-orcid":false,"given":"Marci","family":"English","sequence":"additional","affiliation":[{"name":"Astellas Pharma Inc.  Northbrook IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,4,15]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000282763.29778.59"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000259085.61898.9e"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70143-5"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.PHM.0000154905.18445.0F","article-title":"Management of peripheral neuropathic pain","volume":"84","author":"Stacey BR","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.11.013"},{"key":"e_1_2_9_7_1","first-page":"Cd005429","article-title":"Which anticholinergic drug for overactive bladder symptoms in adults","volume":"1","author":"Madhuvrata P","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002508-200211000-00002"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.03.002"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.04.007"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2006.04.013"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-12-92"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200927020-00002"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2012.729548"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2015.04.031"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.12.004"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2011.09.014"},{"key":"e_1_2_9_18_1","first-page":"518716","article-title":"Clinical characteristics, patient\u2010reported outcomes, and previous therapeutic management of patients with uncontrolled neuropathic pain referred to pain clinics","volume":"2014","author":"Andres J","year":"2014","journal-title":"Pain Res Treat"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.02.034"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12502"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.04.009"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-6-62"},{"key":"e_1_2_9_23_1","volume-title":"The Discovery of Grounded Theory: Strategies for Qualitative Research","author":"Glaser BG","year":"1967"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.4135\/9781446221792.n3"},{"key":"e_1_2_9_25_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) andCenter for Devices and Radiological Health (CDRH).Guidance for industry. Patient\u2010reported outcome measures: use in medical product development to support labeling claims;2009."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990902774765"},{"key":"e_1_2_9_27_1","volume-title":"MOS Sleep Scale Survey Instrument","author":"Rand Health"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00434408"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"e_1_2_9_30_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) andCenter for Devices and Radiological Health (CDRH).Guidance for industry. Analgesic indications: developing drug and biological products draft guidance;2014."},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gaitpost.2008.01.004"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153651"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-014-0171-7"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.03.008"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.11.013"}],"container-title":["Health Expectations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhex.12673","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hex.12673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T09:31:18Z","timestamp":1694943078000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hex.12673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,15]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1111\/hex.12673"],"URL":"https:\/\/doi.org\/10.1111\/hex.12673","archive":["Portico"],"relation":{},"ISSN":["1369-6513","1369-7625"],"issn-type":[{"value":"1369-6513","type":"print"},{"value":"1369-7625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,15]]},"assertion":[{"value":"2017-12-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}